Functional defects in NOD2 signaling in experimental and human Crohn disease

Daniele Corridoni1, Kristen O Arseneau1, Fabio Cominelli1

  • 1Department of Medicine; Case Western Reserve University; Cleveland, OH USA; Digestive Health Research Center; Case Western Reserve University; Cleveland, OH USA.

Gut Microbes
|March 19, 2014
PubMed

Insights

A deficit in innate immunity, not an overactive immune response, may cause Crohn's disease (CD). Impaired NOD2 signaling in mice lacking genetic mutations suggests new therapeutic targets for inflammatory bowel disease.

Area of Science:

  • Immunology
  • Gastroenterology
  • Genetics

Background:

  • Inflammatory bowel disease (IBD) pathogenesis is increasingly linked to innate immune system deficits.
  • Genetic association of Crohn disease (CD) with NOD2 gene polymorphisms supports this hypothesis.
  • NOD2 mutations are the most frequent genetic defect observed in CD patients.

Purpose of the Study:

  • To investigate the role of NOD2 signaling in innate immunity and intestinal inflammation.
  • To examine if a functional deficit in NOD2 signaling, independent of genetic mutations, predisposes to CD-like ileitis.
  • To explore a new paradigm for CD pathogenesis rooted in innate immune deficiency.

Main Methods:

  • Utilized SAMP1/YitFc mice, a model developing CD-like ileitis without NOD2 genetic mutations.
  • Administered MDP (muramyl dipeptide) to assess innate immune response.
  • Measured innate cytokine production and bacterial clearance capacity before disease onset.

Main Results:

  • SAMP1/YitFc mice showed decreased innate cytokine production upon MDP administration.
  • These mice also exhibited impaired bacterial clearance prior to disease manifestation.
  • Findings indicate a functional defect in NOD2 signaling contributes to intestinal inflammation.

Conclusions:

  • Dysregulated NOD2 signaling, whether genetic or functional, predisposes individuals to chronic intestinal inflammation.
  • Crohn disease may arise from a deficit in innate immunity rather than an overly aggressive immune response.
  • This revised understanding offers potential for novel preventative and therapeutic strategies for CD.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
33